Frequency of candida infection among intensive care unit patients and their susceptibility profile

---

Original Article

Author Details : Ayushi Jain, Umar Farooq*, Sudhir Singh, Vasundhara Sharma, Shweta R Sharma, Imran Ahamad

Volume : 7, Issue : 3, Year : 2021

Article Page : 133-136

https://doi.org/10.18231/j.ijmmtd.2021.029

Suggest article by email

Get Permission

---

Abstract

Background: Candida species are responsible for causing many health care associated and central line associated infections. They are responsible for causing opportunistic infection in human beings. Genus of Candida is composed of a heterogeneous group of organsims.Invasive infections of Candida mainly caused by Candida albicans, Candida glabrata, Candida parapsilosis & Candida tropicalis.
Aim and objective: The main objective of this study was to isolates candida albicans and Non- albicans candida and their antifungal susceptibility testing.
Materials and Methods: The study was carried out in the Department of Microbiology, in Tmu Hospital Moradabad. Total numbers of 806 clinical samples were processed in which 206 isolates were taken for candida. Isolation and antifungal susceptibility testing done by Vitek-2 system.
Result: Out of 206 samples 77(37%) were C.albicans and 129(63%) were Non-albicans candida (NAC). Maximum isolated species were C.albicans 77(37%), followed by C.tropicalis 70(34%), C. parapsilosis 24(12%), C. glabrata 19(9%), C. dubliniensis 12(6%), C. krusei 3(1%), C.african 1(1%). 
Conclusion: Infection caused by NAC species have increased. C.tropicalis was the most common isolated species. Candida albicans, C.glabrata and C.krusei were shown high susceptibility to fluconazole and voriconazole. Amphotericin B, Caspofungin, Micafungin and Flucytosine shows high susceptibility towards other candida species.

Keywords: Candida species, Non-albicans candida, Antifungal Susceptibility Testing

How to cite : Jain A, Farooq U, Singh S, Sharma V, Sharma S R, Ahamad I, Frequency of candida infection among intensive care unit patients and their susceptibility profile. IP Int J Med Microbiol Trop Dis 2021;7(3):133-136

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.